Breaking Aaron Donald Works Out With Los Angeles Rams, Fueling Return Speculation IndyCar Set for Washington D.C. Debut with ‘Freedom 250 Grand Prix’ The Perils of Procrastination: Why Gardeners Must Harvest Vegetables at the Right Time Hiroshima Marks 81st Anniversary of Atomic Bombing, Mayor Calls for Nuclear Disarmament US Suspends Avocado Inspections in Michoacan Amid Security Concerns

Thursday August 6, 2026

Reporter

Acrivon Therapeutics, Inc

2Articles Published

5Communities Covered

Published Articles

Press Release

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

16 hours ago

Press Release

Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference

Jul 21